Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD

Denosumab in multiple myeloma patients with renal insufficiency

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel

The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma

Brigatinib for NSCLC, latest research and overcoming complications

Sym015 shows superior specificity compared to TKIs for NSCLC

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma

Update from KAITLIN for high-risk HER2-positive early breast cancer

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

Better genetic diagnostics in Ugandan breast cancer patients